{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:42:58Z","timestamp":1775490178401,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018998","name":"Ege University Research Foundation","doi-asserted-by":"publisher","award":["TGA-2022-23376"],"award-info":[{"award-number":["TGA-2022-23376"]}],"id":[{"id":"10.13039\/501100018998","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11845-022-03231-3","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T20:08:30Z","timestamp":1669406910000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto\u2019s thyroiditis"],"prefix":"10.1007","volume":"192","author":[{"given":"Hatice","family":"Ozisik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Cekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asl\u0131","family":"Suner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buket","family":"Ozel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Selvi","family":"Gunel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Ozgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"3231_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A et al (2015) Autoimmune thyroid disorders. Autoimmun Rev 14:174\u2013180","journal-title":"Autoimmun Rev"},{"key":"3231_CR2","doi-asserted-by":"publisher","first-page":"J156","DOI":"10.1016\/j.jaut.2011.11.003","volume":"38","author":"DP Bogdanos","year":"2012","unstructured":"Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156\u2013J169","journal-title":"J Autoimmun"},{"key":"3231_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","volume":"9","author":"Y Tomer","year":"2014","unstructured":"Tomer Y (2014) Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol 9:147\u2013156","journal-title":"Annu Rev Pathol"},{"key":"3231_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3109\/08916934.2015.1134507","volume":"49","author":"M Akahane","year":"2016","unstructured":"Akahane M, Watanabe M, Inoue N et al (2016) Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases. Autoimmunity 49:312\u2013319","journal-title":"Autoimmunity"},{"key":"3231_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/jpbs.JPBS_746_20","volume":"13","author":"IB Raoof","year":"2021","unstructured":"Raoof IB, Mohsin RA, Okhti ZA (2021) The prevalence role of monocyte chemoattractant protein-1 in Hashimoto\u2019s thyroiditis via various stimuli mechanisms. J Pharm Bioallied Sci 13:244\u2013247","journal-title":"J Pharm Bioallied Sci"},{"key":"3231_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ13-0484","volume":"61","author":"RM Ruggeri","year":"2014","unstructured":"Ruggeri RM, Saitta S, Cristani M et al (2014) Serum interleukin-23 (IL-23) is increased in Hashimoto\u2019s thyroiditis. Endocr J 61:359\u2013363","journal-title":"Endocr J"},{"key":"3231_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"3231_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1365-2249.1998.00628.x","volume":"113","author":"JR de la Vega","year":"1998","unstructured":"de la Vega JR, Vilaplana JC, Biro A et al (1998) IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol 113:126\u2013135","journal-title":"Clin Exp Immunol"},{"key":"3231_CR9","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/eji.1830240629","volume":"24","author":"O Rott","year":"1994","unstructured":"Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24:1434\u20131440","journal-title":"Eur J Immunol"},{"key":"3231_CR10","doi-asserted-by":"crossref","unstructured":"O'Sullivan ST, Lederer JA, Horgan AF et al (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482\u201390; discussion 90\u20132","DOI":"10.1097\/00000658-199522240-00006"},{"key":"3231_CR11","doi-asserted-by":"crossref","unstructured":"Mehrabian M, Sparkes RS, Mohandas T et al (1991) Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1. Genomics 9:200\u20133","DOI":"10.1016\/0888-7543(91)90239-B"},{"key":"3231_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000490189","volume":"27","author":"M Gulgun","year":"2018","unstructured":"Gulgun M (2018) The level of monocyte chemoattractant protein-1 may be affected by several factors. Med Princ Pract 27:400","journal-title":"Med Princ Pract"},{"key":"3231_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cyto.2017.02.001","volume":"98","author":"T Yoshimura","year":"2017","unstructured":"Yoshimura T (2017) The production of monocyte chemoattractant protein-1 (MCP-1)\/CCL2 in tumor microenvironments. Cytokine 98:71\u201378","journal-title":"Cytokine"},{"key":"3231_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","volume":"59","author":"EH Kemp","year":"2003","unstructured":"Kemp EH, Metcalfe RA, Smith KA et al (2003) Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:207\u2013213","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3231_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/JOE-12-0335","volume":"215","author":"M Salzano","year":"2012","unstructured":"Salzano M, Russo E, Postiglione L et al (2012) Interferon-\u03b3 inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells. J Endocrinol 215:439\u2013444","journal-title":"J Endocrinol"},{"key":"3231_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/EBC20190082","volume":"64","author":"WW Christie","year":"2020","unstructured":"Christie WW, Harwood JL (2020) Oxidation of polyunsaturated fatty acids to produce lipid mediators. Essays Biochem 64:401\u2013421","journal-title":"Essays Biochem"},{"key":"3231_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR (2014) Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13:391\u2013397","journal-title":"Autoimmun Rev"},{"key":"3231_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/thy.2012.0554","volume":"23","author":"P Caturegli","year":"2013","unstructured":"Caturegli P, De Remigis A, Chuang K et al (2013) Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23:142\u2013150","journal-title":"Thyroid"},{"key":"3231_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0035-1548832","volume":"47","author":"RA Ajjan","year":"2015","unstructured":"Ajjan RA, Weetman AP (2015) The pathogenesis of Hashimoto\u2019s thyroiditis: further developments in our understanding. Horm Metab Res 47:702\u2013710","journal-title":"Horm Metab Res"},{"key":"3231_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","volume":"52","author":"R Gonz\u00e1lez-Amaro","year":"2016","unstructured":"Gonz\u00e1lez-Amaro R, Marazuela M (2016) T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine 52:30\u201338","journal-title":"Endocrine"},{"key":"3231_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biocel.2017.08.002","volume":"90","author":"S Yu","year":"2017","unstructured":"Yu S, Qi Y, Wang H et al (2017) Dysfunction of CD24+CD38+ B cells in patients with Hashimoto\u2019s thyroiditis is associated with a lack of interleukin 10. Int J Biochem Cell Biol 90:114\u2013120","journal-title":"Int J Biochem Cell Biol"},{"key":"3231_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/08820139.2017.1322975","volume":"46","author":"Y Takuse","year":"2017","unstructured":"Takuse Y, Watanabe M, Inoue N et al (2017) Association of IL-10-regulating MicroRNAs in peripheral blood mononuclear cells with the pathogenesis of autoimmune thyroid disease. Immunol Invest 46:590\u2013602","journal-title":"Immunol Invest"},{"key":"3231_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1523-1747.ep12363613","volume":"101","author":"R Gillitzer","year":"1993","unstructured":"Gillitzer R, Wolff K, Tong D et al (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101:127\u2013131","journal-title":"J Invest Dermatol"},{"key":"3231_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0165-5728(97)00208-7","volume":"84","author":"JE Simpson","year":"1998","unstructured":"Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN (1998) Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238\u2013249","journal-title":"J Neuroimmunol"},{"key":"3231_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4049\/jimmunol.149.2.722","volume":"149","author":"PM Villiger","year":"1992","unstructured":"Villiger PM, Terkeltaub R, Lotz M (1992) Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 149:722\u2013727","journal-title":"J Immunol"},{"key":"3231_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1046\/j.1365-2249.1998.00519.x","volume":"111","author":"S Hashimoto","year":"1998","unstructured":"Hashimoto S, Nakayama T, Gon Y et al (1998) Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 111:604\u2013610","journal-title":"Clin Exp Immunol"},{"key":"3231_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256:137\u2013165","journal-title":"Cancer Lett"},{"key":"3231_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/IGC.0b013e3181e5c442","volume":"20","author":"MA Geller","year":"2010","unstructured":"Geller MA, Bui-Nguyen TM, Rogers LM, Ramakrishnan S (2010) Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer. Int J Gynecol Cancer 20:918\u2013925","journal-title":"Int J Gynecol Cancer"},{"key":"3231_CR29","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","volume":"86","author":"MA Garc\u00eda-L\u00f3pez","year":"2001","unstructured":"Garc\u00eda-L\u00f3pez MA, Sancho D, S\u00e1nchez-Madrid F, Marazuela M (2001) Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86:5008\u20135016","journal-title":"J Clin Endocrinol Metab"},{"key":"3231_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0014-5793(96)00935-0","volume":"394","author":"K Kasai","year":"1996","unstructured":"Kasai K, Banba N, Motohashi S et al (1996) Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes. FEBS Lett 394:137\u2013140","journal-title":"FEBS Lett"},{"key":"3231_CR31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/00365513.2018.1517420","volume":"78","author":"N R\u0103c\u0103t\u0103ianu","year":"2018","unstructured":"R\u0103c\u0103t\u0103ianu N, Leach NV, Bolboac\u0103 SD et al (2018) Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link? Scand J Clin Lab Invest 78:560\u2013565","journal-title":"Scand J Clin Lab Invest"},{"key":"3231_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-3083.2010.02425.x","volume":"72","author":"Y Shi","year":"2010","unstructured":"Shi Y, Wang H, Su Z et al (2010) Differentiation imbalance of Th1\/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto\u2019s thyroiditis. Scand J Immunol 72:250\u2013255","journal-title":"Scand J Immunol"},{"key":"3231_CR33","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1002\/eji.1830271228","volume":"27","author":"C Roura-Mir","year":"1997","unstructured":"Roura-Mir C, Cat\u00e1lfamo M, Sospedra M et al (1997) Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto\u2019s and Graves\u2019 disease. Eur J Immunol 27:3290\u20133302","journal-title":"Eur J Immunol"},{"key":"3231_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/thy.1996.6.97","volume":"6","author":"M Heuer","year":"1996","unstructured":"Heuer M, Aust G, Ode-Hakim S (1996) Different cytokine mRNA profiles in Graves\u2019 disease, Hashimoto\u2019s thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6:97\u2013106","journal-title":"Thyroid"},{"key":"3231_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084545","volume":"9","author":"H Guo","year":"2014","unstructured":"Guo H, Peng D, Yang XG et al (2014) A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto\u2019s thyroiditis. PLoS ONE 9:e84545","journal-title":"PLoS ONE"},{"key":"3231_CR36","doi-asserted-by":"crossref","unstructured":"Setoguchi J, Nakano K, Tsutsumi Y et al (1991) Interferon-alpha and gamma product in peripheral blood of patients with thyroid diseases. Nihon Naibunpi Gakkai Zasshi 67:630\u20135","DOI":"10.1507\/endocrine1927.67.5_630"},{"key":"3231_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2249.2009.03897.x","volume":"156","author":"J Jiskra","year":"2009","unstructured":"Jiskra J, Antosov\u00e1 M, L\u00edmanov\u00e1 Z et al (2009) The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases. Clin Exp Immunol 156:211\u2013216","journal-title":"Clin Exp Immunol"},{"key":"3231_CR38","first-page":"271","volume":"13","author":"S Matsubayashi","year":"1990","unstructured":"Matsubayashi S, Kasuga Y, Sakatsume Y et al (1990) Serum interferon gamma levels in autoimmune thyroid disease. Clin Invest Med 13:271\u2013274","journal-title":"Clin Invest Med"},{"key":"3231_CR39","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1073\/pnas.020522597","volume":"97","author":"P Caturegli","year":"2000","unstructured":"Caturegli P, Hejazi M, Suzuki K et al (2000) Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A 97:1719\u20131724","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3231_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BJ20110327","volume":"437","author":"G Fredman","year":"2011","unstructured":"Fredman G, Serhan CN (2011) Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 437:185\u2013197","journal-title":"Biochem J"},{"key":"3231_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","volume":"15","author":"JN Fullerton","year":"2016","unstructured":"Fullerton JN, Gilroy DW (2016) Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 15:551\u2013567","journal-title":"Nat Rev Drug Discov"},{"key":"3231_CR42","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","volume":"177","author":"JS Duffield","year":"2006","unstructured":"Duffield JS, Hong S, Vaidya VS et al (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177:5902\u20135911","journal-title":"J Immunol"},{"key":"3231_CR43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/a-1345-0173","volume":"129","author":"J Song","year":"2021","unstructured":"Song J, Sun R, Zhang Y, Fu Y, Zhao D (2021a) Role of the specialized pro-resolving mediator resolvin D1 in Hashimoto\u2019s thyroiditis. Exp Clin Endocrinol Diabetes 129:791\u2013797","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3231_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12902-021-00730-9","volume":"21","author":"J Song","year":"2021","unstructured":"Song J, Sun R, Zhang Y, Ke J, Zhao D (2021b) Serum resolvin E1 levels and its relationship with thyroid autoimmunity in Hashimoto\u2019s thyroiditis: a preliminary study. BMC Endocr Disord 21:66","journal-title":"BMC Endocr Disord"},{"key":"3231_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/bph.14336","volume":"176","author":"J Dalli","year":"2019","unstructured":"Dalli J, Serhan CN (2019) Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 176:1024\u20131037","journal-title":"Br J Pharmacol"},{"key":"3231_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jss.2018.07.049","volume":"233","author":"Y Makino","year":"2019","unstructured":"Makino Y, Miyahara T, Nitta J et al (2019) Proresolving lipid mediators resolvin D1 and protectin D1 isomer attenuate neointimal hyperplasia in the rat carotid artery balloon injury model. J Surg Res 233:104\u2013110","journal-title":"J Surg Res"},{"key":"3231_CR47","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1073\/pnas.1617290114","volume":"114","author":"T Gobbetti","year":"2017","unstructured":"Gobbetti T, Dalli J, Colas RA et al (2017) Protectin D1. Proc Natl Acad Sci USA 114:3963\u20133968","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3231_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107486","volume":"94","author":"Z Wu","year":"2021","unstructured":"Wu Z, Lu G, Zhang L et al (2021) Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation. Int Immunopharmacol 94:107486","journal-title":"Int Immunopharmacol"},{"key":"3231_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3892\/etm.2021.10508","volume":"22","author":"Z Wu","year":"2021","unstructured":"Wu Z, Zhang L, Zhao X et al (2021) Protectin D1 protects against lipopolysaccharide-induced acute lung injury through inhibition of neutrophil infiltration and the formation of neutrophil extracellular traps in lung tissue. Exp Ther Med 22:1074","journal-title":"Exp Ther Med"},{"key":"3231_CR50","doi-asserted-by":"crossref","unstructured":"Song MK, Park BB, Uhm J (2019) Understanding immune evasion and therapeutic targeting associated with PD-1\/PD-L1 pathway in diffuse large B-cell lymphoma. Int J Mol Sci 20","DOI":"10.3390\/ijms20061326"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-03231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T08:39:04Z","timestamp":1678783144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-03231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3231"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-03231-3","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"23 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Ege University Faculty of Medicine (21-9\u00a0T\/11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained informed consent from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}